COVID-19 infections and clinical outcomes in patients with multiple myeloma in New York City: a cohort study from five academic centers

M Hultcrantz, J Richter, CA Rosenbaum, D Patel… - Blood cancer …, 2020 - AACR
Patients with multiple myeloma have a compromised immune system, due to both the
disease and antimyeloma therapies, and may therefore be particularly susceptible to COVID …
被引用次数：83 相关文章
[HTML] europepmc.org

[HTML][HTML] COVID-19 infections and outcomes in patients with multiple myeloma in New York City: a cohort study from five academic centers

M Hultcrantz, J Richter, C Rosenbaum, D Patel… - 2020 - europepmc.org
Results Of 100 multiple myeloma patients (male 58%; median age 68, range 41-91)
diagnosed with COVID-19, 74 (74%) were admitted; of these 13 (18%) patients were placed …

COVID-19 infections and outcomes in patients with multiple myeloma in New York City: a cohort study from five academic centers

M Hultcrantz, J Richter, C Rosenbaum, D Patel… - medRxiv, 2020 - medrxiv.org
Abstract Importance New York City is a global epicenter for the SARS-CoV-2 outbreak with a
significant number of individuals infected by the virus. Patients with multiple myeloma have a …
[HTML] nih.gov

[HTML][HTML] COVID-19 Infections and Clinical Outcomes in Patients with Multiple Myeloma in New York City: A Cohort Study from Five Academic Centers

M Hultcrantz, J Richter, CA Rosenbaum… - Blood Cancer …, 2020 - ncbi.nlm.nih.gov
Patients with multiple myeloma have a compromised immune system, due to both the
disease and antimyeloma therapies, and may therefore be particularly susceptible to COVID …

COVID-19 Infections and Clinical Outcomes in Patients with Multiple Myeloma in New York City: A Cohort Study from Five Academic Centers

M Hultcrantz, J Richter, CA Rosenbaum… - Blood cancer …, 2020 - scholarship.miami.edu
Medical records uncover clinical and demographic characteristics associated with severity of
COVID-19 in a large multicenter cohort of patients with multiple myeloma. Patients with …

COVID-19 infections and outcomes in patients with multiple myeloma in New York City: a cohort study from five academic centers

M Hultcrantz, J Richter, C Rosenbaum, D Patel… - 2020 - pesquisa.bvsalud.org
ABSTRACT ImportanceNew York City is a global epicenter for the SARS-CoV-2 outbreak
with a significant number of individuals infected by the virus. Patients with multiple myeloma …

COVID-19 infections and outcomes in patients with multiple myeloma in New York City: a cohort study from five academic centers

M Hultcrantz, J Richter… - … : the preprint server …, 2020 - pubmed.ncbi.nlm.nih.gov
Importance New York City is a global epicenter for the SARS-CoV-2 outbreak with a
significant number of individuals infected by the virus. Patients with multiple myeloma have a …
[HTML] nih.gov

[HTML][HTML] COVID-19 infections and outcomes in patients with multiple myeloma in New York City: a cohort study from five academic centers

M Hultcrantz, J Richter, C Rosenbaum, D Patel… - medRxiv - ncbi.nlm.nih.gov
Objective: To assess risk factors and outcomes of COVID-19 in patients with multiple
myeloma. Design: Case-series. Setting: Five large academic centers in New York City …

COVID-19 Infections and Clinical Outcomes in Patients with Multiple Myeloma in New York City: A Cohort Study from Five Academic Centers

M Hultcrantz, J Richter… - Blood cancer …, 2020 - pubmed.ncbi.nlm.nih.gov
Patients with multiple myeloma have a compromised immune system, due to both the
disease and antimyeloma therapies, and may therefore be particularly susceptible to COVID …

COVID-19 Infections and Clinical Outcomes in Patients with Multiple Myeloma in New York City: A Cohort Study from Five Academic Centers.

M Hultcrantz, J Richter, CA Rosenbaum… - Blood Cancer …, 2020 - europepmc.org
Patients with multiple myeloma have a compromised immune system, due to both the
disease and antimyeloma therapies, and may therefore be particularly susceptible to COVID …